SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-13-001506
Filing Date
2013-04-01
Accepted
2013-04-01 14:01:14
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K pharmagen_10k.htm 10-K 1266187
2 CERTIFICATION pharmagen_ex311.htm EX-31.1 13391
3 CERTIFICATION pharmagen_ex312.htm EX-31.2 13089
4 CERTIFICATION pharmagen_ex321.htm EX-32.1 6236
5 CERTIFICATION pharmagen_ex322.htm EX-32.2 5736
  Complete submission text file 0001477932-13-001506.txt   4154327

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT phrx-20121231.xml EX-101.INS 345760
7 XBRL TAXONOMY EXTENSION SCHEMA phrx-20121231.xsd EX-101.SCH 46852
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phrx-20121231_cal.xml EX-101.CAL 42527
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phrx-20121231_def.xml EX-101.DEF 86720
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE phrx-20121231_lab.xml EX-101.LAB 269435
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phrx-20121231_pre.xml EX-101.PRE 191115
Mailing Address 9337 FRASER AVE. SILVER SPRING MD 20910
Business Address 9337 FRASER AVE. SILVER SPRING MD 20910 (204) 898-8160
Pharmagen, Inc. (Filer) CIK: 0001470915 (see all company filings)

IRS No.: 270777112 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54523 | Film No.: 13730299
SIC: 1000 Metal Mining